SCI Q3 2026 Earnings: Preneed Momentum Meets Margin Headwinds as Cash Returns Roar

Overview of the quarter

Service Corporation International, traded on the NYSE under ticker SCI, disclosed its third quarter 2026 results with a clear signal: growth is broad but margins are being pressed by rising costs. The company reported GAAP earnings per share (EPS) of $1.03, up 24% from the year-ago period, and adjusted EPS of $0.97, up 11%. Consolidated revenue rose 5% year over year, aided by a $49.2 million increase versus the prior year quarter. On the cash-flow line, net cash provided by operating activities climbed to $296.8 million, an 18% year-over-year rise, while adjusted cash from operating activities rose 11% to $296.9 million.

In the near-term, SCI highlighted continued growth in its preneed businesses and cemetery revenue, even as it flagged cost pressures stemming from higher healthcare costs, increased selling compensation, and more aggressive advertising and marketing to fuel preneed sales. The company also underscored that improved trust fund income and lower corporate general and administrative expenses—partially due to reduced long-term incentive compensation tied to total shareholder return—helped offset some margin pressure.

Third Quarter Highlights

GAAP EPS up 24% to $1.03; Adjusted EPS up 11% to $0.97.
Consolidated revenue up $49.2 million, or 5%, versus Q3 2025.
Operating cash flow: $296.8 million, up 18% year over year; adjusted cash from operating activities: $296.9 million, up 11%.
Preneed sales production: funeral preneed up about 6%; cemetery preneed up about 5% year over year.
Comparable funeral revenue grew roughly 3%; comparable cemetery preneed sales revenue grew in the mid-single digits, with overall preneed dynamics driving long-term growth.
Capital returns: year to date, SCI has returned about $464 million to shareholders via dividends and share repurchases.

Management commentary and what it signals

Tom Ryan, SCI’s Chairman and CEO, framed the results as evidence of ongoing discipline and a durable earnings trajectory. He noted that the quarter’s adjusted EPS of $0.97 and adjusted net cash from operating activities of $296.9 million delivered double-digit growth versus the prior-year quarter. The company highlighted solid performance in the funeral segment, supported by higher revenue per service and steady volumes, while the cemetery segment benefited from stronger preneed activity and revenue mix shifts.

Key to SCI’s narrative is the preneed backbone. Preneed sales production rose meaningfully across both funeral and cemetery lines, with cemetery preneed activity contributing to higher recognized preneed cemetery property revenue. Management also emphasized that backlogs in preneed property sales and related revenue recognition provide a path to higher-margin earnings in future periods, even as near-term costs compress margins.

On the cost side, SCI pointed to higher healthcare costs and selling compensation, plus elevated advertising and marketing expenditure tied to preneed growth initiatives. These headwinds were, however, only partially offset by higher trust fund income and a reduction in certain G&A expenses tied to long-term incentive compensation aligned with shareholder-return goals.

Beyond the quarter itself, SCI reiterated its commitment to deploying capital across growth opportunities—acquisitions, cemetery property development, and real estate investments—while returning substantial capital to shareholders. The tone suggests a balance sheet and cash-flow profile that can support continued buybacks and dividends even as margins adjust to a higher-cost environment.

Outlook and near-term outlook

The release notes ongoing discussions about the fourth-quarter outlook and confirms a conference call on Thursday, October 29, 2026, at 8:00 a.m. Central Time. While specific revenue forecasts or EPS consensus figures for Q4 were not laid out in dramatic detail, the narrative implies continued growth in preneed volumes and cemetery-related revenue, offset by ongoing cost pressures. Investors should watch for any updated guidance on the revenue forecast and EPS trajectory as the company completes the seasonal year-end period.

Implications for SCI and sector peers

SCI’s results illustrate a familiar pattern in essential services: real, attribute-rich growth in higher-margin, long-tailed revenue streams (preneed and property-related revenue) can underpin earnings while the more volatile, variable-cost components (healthcare-related costs, marketing spend) press on margins. The company’s ability to translate preneed growth into recognized revenue and to fund capital returns suggests a resilient model that can attract patient and consumer-stakeholder confidence even as costs rise.

For peers in the deathcare space, SCI’s quarter underscores three themes: the importance of preneed execution and revenue recognition timing, the macro-cost backdrop impacting margins, and the ongoing role of capital returns in maintaining investor appeal. If competitors can replicate SCI’s mix of growth in preneed sales and disciplined capital allocation, they may sustain earnings momentum even as the industry contends with cost inflation and workforce pressures.

Notes on the filing and interpretation

The figures reported are drawn from SCI’s press release accompanying the SEC filing EX-99.1. The company provided both GAAP and non-GAAP (adjusted) measures, a common practice to depict the underlying operating performance while reconciling to standardized accounting metrics. The absence of a stated explicit “earnings surprise” in the release means readers should compare SCI’s EPS against street estimates using the company’s own EPS consensus data and the forward-looking guidance they outline in the conference call materials.